FDA Requests Removal of All Ranitidine (Zantac) from the Market - based on its investigation of the contaminant N-Nitrosodimethylamine (NDMA) in ranitidine; the impurity in ranitidine products increases over time, esp at higher temps https://t.co/BJxLDfpbtS
Links:
FDA Requests Removal of All Ranitidine Products (Zantac) from the Market | FDA
https://bit.ly/2Jzlktm
Apr-02-2020


